Cure ETF – Buy

Posted on | by Leon Hinde

CURE:AXW is under Algo Engine buy conditions and the current pullback provides another buying opportunity.

ETFS S&P Biotech ETF (ASX Code: CURE) offers investors exposure to U.S. biotechnology companies. These companies are engaged in research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering.

.

China ETF – IZZ

Posted on | by Leon Hinde

ASX:IZZ is under Algo Engine buy conditions. We expect buying interest to increase within the $55 – $60 price range.

Traders may wait for the third factor to align, an upturn in the momentum indicators. Watch for the stochastic to move higher or the price action on the main chart to cross above the 10-day average.

Woolworths – Demerger

Posted on | by Leon Hinde

WOW:ASX is under Algo Engine buy conditions and is a current holding on our ASX model portfolio.

Post demerger Endeavour Drinks will own the largest network of retail alcohol stores in Australia with 1,630 stores. It will also have 332 hotels and 12,400 electronic gaming machines across 1,775 liquor licences.

Endeavour operates across two divisions, Retail and Hotels. Forcast FY22 revenue is likely to be around $10.5bn and EBIT $700m.

WOW shareholders will receive one new Endeavour Group share for every WOW share held at the demerger record date (25-June). Post the demerger WOW will likely consider the potential for capital management of $1.6bn-$2bn.

CIMIC – Trade Update

Posted on | by Leon Hinde

CIM:ASX is likely to see improved earnings in FY22 and we expect to soon see a recovery in the share price.

CIMIC is a high risk counter trend investment with the prospect of a multi-year recovery, once earnings hit an inflection point.

24/4 CIMIC breaks above the 10-day average after forming a new trend low mid-week at $16.86.

10/5 Dec 21 $20 call options are now trading at $1.10.


China ETF – IZZ

Posted on | by Leon Hinde

ASX:IZZ is under Algo Engine buy conditions. We expect buying interest to increase within the $55 – $60 price range.

10/5 Traders may wait for the third factor to align, an upturn in the momentum indicators. Watch for the stochastic to move higher or the price action on the main chart to cross above the 10-day average.

Cure ETF – Buy

Posted on | by Leon Hinde

CURE:AXW is under Algo Engine buy conditions and the current pullback provides another buying opportunity.

ETFS S&P Biotech ETF (ASX Code: CURE) offers investors exposure to U.S. biotechnology companies. These companies are engaged in research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering.

.